Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess.

[1]  R. Azziz,et al.  Adrenocortical secretion of dehydroepiandrosterone in healthy women: highly variable response to adrenocorticotropin. , 2001, The Journal of clinical endocrinology and metabolism.

[2]  R. Azziz,et al.  A multicenter study of women with nonclassical congenital adrenal hyperplasia: relationship between genotype and phenotype. , 2000, Molecular genetics and metabolism.

[3]  J. Martens,et al.  Enzymatic activities of P450c17 stably expressed in fibroblasts from patients with the polycystic ovary syndrome. , 2000, The Journal of clinical endocrinology and metabolism.

[4]  R. Azziz,et al.  Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study. , 1999, Fertility and sterility.

[5]  R. Azziz,et al.  Prevalence of 3beta-hydroxysteroid dehydrogenase-deficient nonclassic adrenal hyperplasia in hyperandrogenic women with adrenal androgen excess. , 1999, American journal of obstetrics and gynecology.

[6]  W L Miller,et al.  Medroxyprogesterone acetate and dexamethasone are competitive inhibitors of different human steroidogenic enzymes. , 1999, The Journal of clinical endocrinology and metabolism.

[7]  R. Azziz,et al.  Adrenal androgen excess in hyperandrogenism: relation to age and body mass. , 1999, Fertility and sterility.

[8]  T. Key,et al.  Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. , 1998, The Journal of clinical endocrinology and metabolism.

[9]  R. Azziz,et al.  Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis. , 1998, The Journal of clinical endocrinology and metabolism.

[10]  W. Miller,et al.  Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer* , 1998, The Journal of Biological Chemistry.

[11]  R. Azziz,et al.  Measurement of total serum testosterone levels using commercially available kits: high degree of between-kit variability. , 1998, Fertility and sterility.

[12]  W. Miller,et al.  The regulation of 17,20 lyase activity , 1997, Steroids.

[13]  T. Yanase.  17α-Hydroxylase/17,20-lyase defects , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[14]  J. Simard,et al.  Molecular basis of human 3β-hydroxysteroid dehydrogenase deficiency , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[15]  R. Azziz,et al.  Adrenal androgen excess in women: lack of a role for 17-hydroxylase and 17,20-lyase dysregulation. , 1995, The Journal of clinical endocrinology and metabolism.

[16]  R. Legro,et al.  Polycystic ovary syndrome. , 1992, Current therapy in endocrinology and metabolism.

[17]  R. Azziz,et al.  3β-Hydroxysteroid dehydrogenase deficiency in hyperandrogenism , 1993 .

[18]  R. Lobo,et al.  Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? , 1992, American journal of obstetrics and gynecology.

[19]  R. Azziz,et al.  The effects of prolonged hypertestosteronemia on adrenocortical biosynthesis in oophorectomized women. , 1991, The Journal of clinical endocrinology and metabolism.

[20]  R. Azziz,et al.  11β-Hydroxylase deficiency in hyperandrogenism * † , 1991 .

[21]  A. Lucky,et al.  Dysregulation of cytochrome P450c17α as the cause of polycystic ovarian syndrome , 1990 .

[22]  R. Azziz,et al.  Acute adrenocorticotropin-(1-24) (ACTH) adrenal stimulation in eumenorrheic women: reproducibility and effect of ACTH dose, subject weight, and sampling time. , 1990, The Journal of clinical endocrinology and metabolism.

[23]  R. Azziz,et al.  21-Hydroxylase deficiency in female hyperandrogenism: screening and diagnosis. , 1989, The Journal of clinical endocrinology and metabolism.

[24]  D. Ehrmann,et al.  Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. , 1989, The New England journal of medicine.

[25]  A. Lucky,et al.  Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche. , 1986, The Journal of clinical endocrinology and metabolism.

[26]  R. Wild,et al.  Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism. , 1983, American journal of obstetrics and gynecology.

[27]  M. Kim,et al.  Hirsutism: implications, etiology, and management. , 1981, American journal of obstetrics and gynecology.

[28]  J. Buster,et al.  Ovarian and Adrenal Contributions to Peripheral Androgens in Hirsute Women , 1975, Obstetrics and gynecology.

[29]  W. H. Pearlman,et al.  Steroid-protein interaction with particular reference to testosterone binding by human serum. , 1967, The Journal of biological chemistry.